期刊文献+

巨噬细胞移动抑制因子在非IgA系膜增生性肾小球肾炎肾组织中的表达 被引量:5

Expression and significance of macrophage migration inhibitory factor in non-IgA mesangioproliferative glomerulonephritis
暂未订购
导出
摘要 目的探讨巨噬细胞移动抑制因子(MIF)在非IgA系膜增生性肾小球肾炎患者肾组织中的表达及其意义。方法应用免疫组织化学双标记技术检测正常对照组及不同病变程度非IgA系膜增生性肾小球肾炎患者肾组织内MIF和人巨噬细胞标记抗原CD68的表达。结果在正常对照组和IgA系膜增生性肾小球肾炎患者轻度组仅有少量MIF和CD68表达。随着非IgA系膜增生性肾小球肾炎病变程度的加重,MIF、CD68的表达逐渐增强,重度病变时,MIF、CD68的表达最强,且MIF表达水平与CD68表达呈正相关(r=0.87,P<0.01)。结论肾组织内MIF表达上调所导致的巨噬细胞浸润增加可能是非IgA系膜增生性肾小球肾炎进展的重要机制之一。 Purpose To explore the expression and significance of macrophage migration inhibitory factor (MIF) in the kidney of patients with non-IgA mesangial proliferative glomerulonephritis (MsPGN). Methods MIF protein expression and the marker of human maerophage ( CD68 ) in renal tissue of non-IgA MsPGN were detected with a double labeling immunostaining method. Results Weak expression of MIF and CD68 was found in normal control and mild groups, and with the advancement of the disease, the expression of MIF and CD68 was gradually increased. Among all the groups, the expression of MIF and CD68 was the strongest in severe groups, and the expression of MIF was correlated with that of CD68. Conclusions It may be an important mechanism for the progression of non- IgA MsPGN that upregulation of MIF can enhance infiltration of macrophages.
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2007年第2期175-177,共3页 Chinese Journal of Clinical and Experimental Pathology
基金 国家自然基金"创新研究群体"项目(30121005)
关键词 巨噬细胞移动抑制因子 非IGA系膜增生性肾小球肾炎 CD68 Maerophage migration inhibitory factor CD68 non-IgA mesangioproliferative glomerulonephritis
  • 相关文献

参考文献11

  • 1Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity [J]. Nat Rev Immunol, 2003,3(10):791-800.
  • 2Lan H Y, Yang N, Nikolic-Paterson D J, et al. Expression of macrophage migration inhibitory factor in human glomerulonephritis[J]. Kidney Int,2000,57(2):499-509.
  • 3Morand E F, Leech M, Bemhagen J. MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis [J]. Nat Rev Drug Discov, 2006,5(5):399-410.
  • 4Sasaki S, Nishihira J, Ishibashi T, et al. Transgene of MIF induces podocyte injury and progressive mesangial sclerosis in the mouse kidney [J]. Kidney Int, 2004,65(2):469-481.
  • 5Rice E K, Tesch G H, Cao Z, et al. Induction of MIF synthesis and secretion by tubular epithelial cells: a novel action of angiotensin Ⅱ [J]. Kidney Int, 2003,63(4):1265-1275.
  • 6Brown F G, Nikolic-Paterson D J, Hill P A, et al. Urine macrophage migration inhibitory factor reflects the severity of renal injury in human glomerulonephritis [J]. J Am Soc Nephrol, 2002,13 Suppl 1: S7-13.
  • 7Leung J C, Chan L Y, Tsang A W, et al. Anti-macrophage migration inhibitory factor reduces transforming growth factor-beta I expression in experimental IgA nephropathy [J]. Nephrol Dial Transplant, 2004,19(8):1976-1985.
  • 8Amin M A, Haas C S, Zhu K, et al. Migration inhibitory factor up-regulates vascular cell adhesion molecule-I and intercellular adhesion molecule-1 via Src, PI3 kinase, and NF kappaB [J]. Blood,2006,107(6):2252-2261.
  • 9Aeberli D, Yang Y, Mansell A, et al. Endogenous macrophage migration inhibitory factor modulates glucocorticoid sensitivity in macrophages via effects on MAP kinase phosphatase-I and p38 MAP kinase[J]. FEBS Lett, 2006,580(3):974-981.
  • 10Cao W G, Morin M, Sengers V, et al. Tumour necrosis factor-alpha up-regulates macrophage migration inhibitory factor expression in endometrial stromal cells via the nuclear transcription factor NFkappaB[J]. Hum Reprod, 2006,21(2):421-428.

同被引文献48

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部